RxDoctor Payments Data

Sharrell Cooper, MD

Family Medicine · Palm Coast, FLNPI 1588094130

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Novo Nordisk at 35.3% of the total. Reporting peaked in 2022 at $239 and has fallen 93.0% since, to $17 in 2023.

$710in general payments, 2019–2025

Across 41 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$251
  • Merck$90
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • Lilly USA, LLC$46
  • Boehringer Ingelheim$44
  • AbbVie$43
  • plus $178 from 7 others
$16,886,298in research payments, 2019–2025

Across 47 payments — averaging $359,283 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$13.3M
  • Genentech, Inc.$3M
  • Eli Lilly$521K

What the payments were for

  • Food & beverage$710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$710 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$2,008
Medicare patients
14
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Palm Coast

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →